Table: Jcr Pharmaceuticals -2021/22 group results

JCR Pharmaceuticals

12/05/2022 08:00

May 12 (Reuters)- 
          Jcr Pharmaceuticals Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             51.08           30.09          45.00                 
                 (+69.8 pct)     (+21.4 pct)    (-11.9 pct)              
  Operating         19.93            8.27          14.50                 
                (+141.1 pct)    (+154.9 pct)    (-27.3 pct)              
  Recurring         20.51            8.49          14.50                 
                (+141.6 pct)    (+157.7 pct)    (-29.3 pct)              
  Net
  Net               14.51            6.89          10.30                 
                (+110.5 pct)    (+157.4 pct)    (-29.0 pct)              
  EPS            117.26 yen       55.81 yen      83.25 yen               
  EPS Diluted    116.80 yen       55.53 yen                              
  Ann Div         22.00 yen                      20.00 yen               
  -Q2 Div         10.00 yen       18.00 yen      10.00 yen               
  -Q4 Div         12.00 yen       7.50 yen       10.00 yen               
  
  NOTE - Jcr Pharmaceuticals Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T